Status:
COMPLETED
Biomarkers in Tissue Samples From Patients With Ewing Sarcoma
Lead Sponsor:
Children's Oncology Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Sarcoma
Eligibility:
All Genders
Up to 50 years
Brief Summary
RATIONALE: Studying samples of tissue in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. It may also help doctors understand how w...
Detailed Description
OBJECTIVES: * To describe the spectrum of GGAA-microsatellite polymorphisms at specific loci in genomic DNA prepared from Ewing sarcoma tumor specimens. * To determine if there are differences in GGA...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Specimens from patients with Ewing sarcoma used for protocol COG-AEWS08B1
- Obtained from patient samples taken from patients enrolled on COG-AEWS0031
- Whole genome-amplified DNA will be used
- PATIENT CHARACTERISTICS:
- Not specified
- PRIOR CONCURRENT THERAPY:
- Not specified
Exclusion
Key Trial Info
Start Date :
December 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2012
Estimated Enrollment :
166 Patients enrolled
Trial Details
Trial ID
NCT01480518
Start Date
December 1 2011
End Date
January 1 2012
Last Update
May 12 2015
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.